A Review of Isozymes in Cancer1

Total Page:16

File Type:pdf, Size:1020Kb

A Review of Isozymes in Cancer1 Cancer Research VOLUME31 NOVEMBER 1971 NUMBER11 [CANCER RESEARCH 31, 1523-1542, November 1971] A Review of Isozymes in Cancer1 Wayne E. Criss Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32601 TABLE OF CONTENTS postulated role for that particular isozymic system in cellular metabolism. Summary 1523 Introduction 1523 Normal enzyme differentiation 1523 INTRODUCTION Tumor enzyme differentiation 1524 Isozymes 1524 Normal Enzyme Differentiation DNA polymerase 1524 Enzyme differentiation is the process whereby, during the Hexokinase 1525 Fructose 1,6-diphosphatase 1525 development of an organ in an animal, the organ acquires the quantitative and qualitative adult enzyme patterns (122). Key Aldolase 1526 pathway enzymes in several metabolic processes have been Pyruvate kinase 1527 found to undergo enzymatic differentiation. The enzymes Láclatedehydrogenase 1527 Isocitrate dehydrogenase 1527 involved in nitrogen metabolism, and also in urea cycle Malate dehydrogenase 1528 metabolism (180), are tyrosine aminotransferase (123, 151, Glycerol phosphate dehydrogenase 1529 330, 410), tryptophan pyrrolase (261), serine dehydratase Glutaminase 1529 (123, 410), histidine ammonia lyase (11), and aspartate Aspartate aminotransferase 1530 aminotransferase (337, 388). The enzymes involved in nucleic Adenylate kinase 1531 acid metabolism are DNA polymerase (156, 277) and RNase (52). In glycolysis the enzymes are hexokinase-glucokinase Carbamyl phosphate synthetase 1531 Lactose synthetase 1533 (98, 389), galactokinase 30, aldolase (267, 315), pyruvate Discussion 1533 kinase (73, 386), and lactate dehydrogenase (67, 69). In References 1533 mitochondrial oxidation they are NADH oxidase, succinic oxidase, a-glycero-P oxidase, ATPase, cytochrome oxidase, and flavin content (84, 296). In glycogen metabolism the SUMMARY enzymes involved are UDPG pyrophosphorylase and UDPG glucosyltransferase (19). The enzymes involved in glu- Several distinct isozymic systems which were observed to coneogenesis are glucose 6-phosphatase (79), fructose have alterations during differentiation from the normal to the diphosphatase (18), phosphoenolpyruvate carboxylase (21, neoplastic state have been reviewed. Most of these isozymes 413), and pyruvate carboxylase (17). Most of these enzyme are key pathway or regulatory enzymes of intermediary shifts are simple quantitative changes (296, 410) which have metabolism. The isozymic systems which were reviewed been interpreted as the initiation or termination of a metabolic include DNA polymerase, hexokinase-glucokinase, fructose pathway in that tissue. However, some enzymes undergo shifts 1,6-diphosphatase, aldolase, pyruvate kinase, lactate in their isozymic complements (67, 156, 389), thus making dehydrogenase, isocitrate dehydrogenase, malate the overall metabolic interpretation more or less difficult, dehydrogenase, glycerol phosphate dehydrogenase, depending upon how much is known about each isozymic glutaminase, aspartate aminotransferase, adenylate kinase, form. carbamylphosphate synthetase, and lactose synthetase. The With the same type of reasoning, one can assume that the basic isozymic system was outlined, and alterations which disappearance of a key pathway enzyme in neoplastic tissue occurred in the neoplastic state were discussed in terms of the represents a loss of that particular metabolic pathway to the tissue. The question one can ask is, "Do neoplastic tissues have 1This work was supported by the Florida Division of the American a distinctive and unique enzyme pattern just as the normal Cancer Society (Grant F71UF-1). organ systems in an adult animal have distinctive and unique Received April 21, 1971; accepted June 15, 1971. enzyme patterns?" If so, we should be able to examine key NOVEMBER 1971 1523 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 1971 American Association for Cancer Research. Wayne E. Criss pathway enzymes and establish potentially functional and enzymes which exist as multiple forms and which have been potentially obsolete metabolic routes in tumors. found to undergo changes in cancers. Tumor Enzyme Differentiation ISOZYMES Numerous reviews have been written which reported the measurable levels in neoplastic tissues of nearly all of the DNA Polymerase enzymes involved in glycolysis (47, 149, 192, 287, 397, 399, 405, 406), pentose-P metabolism (149, 192), gluconeogenesis Deoxynucleotidyl transferase (DNA polymerase) activity (47, 192, 397), oxidative phosphorylation (219, 399), urea exists throughout nature in a heterogeneous state (37, 110, cycle metabolism (418), and nucleic acid metabolism (58, 125, 111, 160, 179, 258, 269, 270,421, 425). Purified Escherichia 246, 352, 408). It would appear to be very difficult, if not coli DNA polymerase used native and heat-denatured DNA as impossible, to extrapolate the abnormal enzyme patterns primer and formed a complex with native and heat-denatured found in one type of tumor directly into other types of DNA (34, 160). Calf thymus DNA polymerase was purified as malignant tissues. The patterns may vary within different 2 separate and distinct forms, a replicative deoxynucleotidyl tumor tissues in the same animal species and may also deviate transferase which used only denatured DNA as primer and was in similar tumor types from different animal species. a DNA polymerase and a terminal deoxynucleotidyl Weber (397) has presented a "molecular correlation concept transferase which used short-chain oligodeoxynucleotides or of neoplasia" which was based principally upon the Morris denatured DNA as primer and was a terminal addition enzyme "minimal-deviation" hepatoma system (247, 254—256). This (37-41, 167, 216, 421). The thymus enzymes did not concept is an attempt to make a phenotypic complex with DNA and thus probably differ from E. coli description of the metabolism of a "typical" tumor cell as polymerase. DNA polymerases, as purified from regenerating follows. Patterns of carbohydrate metabolism show a decrease rat liver (248) from nonhistone chromosomal proteins of in gluconeogenic capacity and an increase in glycolytic normal rat liver (141) and from sea urchin embryo (220), capacity in the hepatoma cell. The capacity for the synthesis preferentially used native DNA as primer. Different physical of glycogen and lipid is greatly decreased. The tumor cell can and enzymatic (e.g., substrate specificity) properties were synthesize proteins and nucleic acids at increased rates, while observed with nuclear and mitochondrial DNA polymerases the catabolism of amino acids, proteins, and nucleic acids are from normal rat liver and yeast (157, 162, 242). Therefore, as decreased. Thus, it would appear that the hepatoma cell has a generalization, DNA polymerase activity can be classified streamlined its metabolism in an attempt simply to grow and according to preference for native or denatured substrate. multiply. However, one must continuously keep in mind that With Sephadex gel filtration, DNA polymerase activity from the in vitro measurements of enzymes or enzyme systems, adult rat liver has been separated into 2 fractions (156, upon which most of the above-mentioned reviews and much of 275—277). Peak I had a large molecular weight, was isolated the foundation for the molecular correlation concept are from the postmicrosomal supernatant, and worked best with based, are an indication only of the potential activity of heat-denatured DNA as primer. Peak II was smaller, was specific enzymes and their representative metabolic pathways. concentrated in the free ribosomes, and used mainly native Loss of an enzyme may or may not be indicative of a loss of DNA as primer (26, 156). Peak I was the predominant form of the specific pathway in which the enzyme plays a key role. DNA polymerase in malignant tumors and fetal liver. Peak II Also, the presence or even the increase in the activity of a key was the predominant form in adult and regenerating rat liver enzyme (especially from in vitro assays) may not necessarily (275). indicate an increase in the corresponding pathway. However, 3 forms of DNA polymerase from rat liver and The latter statements are particularly true in the situations hepatomas have been observed with phosphocellulose column in which a key enzyme exists in multiple forms and the various chromatography (156, 270, 275-277). Peaks I and II used forms have different modulators. Decreases in one enzyme heat-denatured DNA, and Peak III accepted native DNA as form may be compensated by increases in another enzyme primer. Normal liver and slow-growing hepatomas had similar form, with the net result being an increase, a decrease, or no levels of Peaks I and II and a much smaller level of Peak III. net change in the total activity of that enzyme system. Regenerating and fetal liver and fast-growing hepatomas had Therefore, an examination of the changes in the activity levels higher levels of Peak II than of Peak I and only a very small of one of the isozymic forms of a key enzyme system, a amount of Peak III. DNA polymerase I remained fairly process which occurs naturally during the phenomena of constant, while the II form increased and the III form enzyme differentiation and which was cited earlier in this decreased with increased tissue growth rates. It would appear review, could yield considerable information about the that the predominant form of normal adult rat liver DNA functioning of specific metabolic pathways in the tumor cell, polymerase acts on native DNA but
Recommended publications
  • METACYC ID Description A0AR23 GO:0004842 (Ubiquitin-Protein Ligase
    Electronic Supplementary Material (ESI) for Integrative Biology This journal is © The Royal Society of Chemistry 2012 Heat Stress Responsive Zostera marina Genes, Southern Population (α=0.
    [Show full text]
  • Molecular Characterization of Galactokinase Deficiency In
    J Hum Genet (1999) 44:377–382 © Jpn Soc Hum Genet and Springer-Verlag 1999377 ORIGINAL ARTICLE Minoru Asada · Yoshiyuki Okano · Takuji Imamura Itsujin Suyama · Yutaka Hase · Gen Isshiki Molecular characterization of galactokinase deficiency in Japanese patients Received: May 19, 1999 / Accepted: August 21, 1999 Abstract Galactokinase (GALK) deficiency is an autoso- Key words Galactosemia · Galactokinase (GALK) · Muta- mal recessive disorder, which causes cataract formation in tion · Genotype · Phenotype children not maintained on a lactose-free diet. We charac- terized the human GALK gene by screening a Japanese genomic DNA phage library, and found that several nucle- otides in the 59-untranslated region and introns 1, 2, and 5 in Introduction our GALK genomic analysis differed from published data. A 20-bp tandem repeat was found in three places in intron Galactokinase (GALK: McKUSICK 230200) is the first 5, which were considered insertion sequences. We identified enzyme in the Leloir pathway of galactose metabolism; it five novel mutations in seven unrelated Japanese patients catalyzes the phosphorylation of galactose to galactose- with GALK deficiency. There were three missense muta- 1-phosphate. GALK deficiency, first described in 1965 tions and two deletions. All three missense mutations (Gitzelmann 1965), is an autosomal recessive genetic disor- (R256W, T344M, and G349S) occurred at CpG dinucle- der with an incidence of 1/1,000,000 in Japan (Aoki and otides, and the T344M and G349S mutations occurred in Wada 1988) on newborn mass screening and an incidence of the conserved region. The three missense mutations led to a 1/1,000,000 in Caucasians (Segal and Berry 1995).
    [Show full text]
  • Copyright by Young-Sam Lee 2010
    Copyright by Young-Sam Lee 2010 The Dissertation Committee for Young-Sam Lee Certifies that this is the approved version of the following dissertation: Structural and Functional Studies of the Human Mitochondrial DNA Polymerase Committee: Whitney Yin, Supervisor Ian Molineux Kenneth Johnson Tanya Paull Jon Robertus Structural and Functional Studies of the Human Mitochondrial DNA Polymerase by Young-Sam Lee, B.S, M.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2010 Dedication For my wife, In-Sook Jung. Acknowledgements I would like to appreciate Dr. Whitney Yin for giving me chance to working in her lab and mentoring me through my graduate program. Not only the scientific insights, also the warmness that she gave me and my family encouraged me to pursue my Ph. D. degree in the foreign country. I also would like to thank “a guru of molecular biology” Dr. Ian Molineux and “a guru of enzyme kinetics” Dr. Kenneth Johnson. Without their critical advice, I would not be accomplished my publication. I hope to be a respectable expert in my research field like them. I also should remember friendship and generosity given by many current and former Yin lab members: Hey-Ryung Chang, Qingchao “Eric” Meng, Xu Yang, Jeff Knight, Dr. Michio Matsunaga, Dr. He “River” Quan, Taewung Lee, Xin “Ella” Wang, Jamila Momand, and Max Shay. Most of all, I really appreciate my parents for their endless love and support, and my wife, In-Sook Jung, and my son, Jason Seung-Hyeon Lee who always stand by me with patients during my graduate carrier.
    [Show full text]
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • In the Field of Clinical Examination, the Measurement of Creatine
    J. Clin. Biochem. Nutr., 3, 17-25, 1987 Bacterial Glucokinase as an Enzymic Reagent of Good Stability for Measurement of Creatine Kinase Activity Hitoshi KONDO, * Takanari SHIRAISHI, Masao KAGEYAMA, Kazuhiko NAGATA, and Kosuke TOMITA Research and Development Center, UNITIKA Ltd., Uji 611, Japan (Received January 10, 1987) Summary An enzymic reagent, that has long-term stability even in the liquid state, was successfully employed for the measurement of serum creatine kinase (CK, EC 2.7.3.2) activity. The enzyme used was the thermostable glucokinase (GlcK, EC 2.7.1.2) obtained from the thermo- phile Bacillus stearothermophilus. The reagent was found to be stable in solution for about one month at 6•Ž and for about one week at 30•Ž. This substitution of glucokinase for the hexokinase of the most commonly used hexokinase-glucose-6-phosphate dehydrogenase (HK-G6PDH) method results in a remarkable improvement of the method. The CK activity measured by the GlcK-G6PDH method was linear up to about 2,000 U/ liter at 37•Ž. The GlcK-G6PDH method was found to give a satisfactory precision and reproducibility (coefficient of variation less than 2.17%). Over a wide range of CK activity, an excellent agreement was obtained between the GlcK-G6PDH and the HK-G6PDH methods. Furthermore several coexistents and anticoagulants were found to have little effect on the measured value of CK activity by the GlcK-G6PDH method. Key Words: creatine kinase activity, glucokinase, improved stability of reagent, creatine kinase determination, thermostable enzyme In the field of clinical examination, the measurement of creatine kinase (CK, ATP : creatine phosphotransferase, EC 2.7.3.2) activity in serum is one of the important examinations usually employed for diagnosis of cardiac diseases such as myocardial infarction or muscular diseases such as progressive muscular dystrophy.
    [Show full text]
  • A Mutation in DNA Polymerase Α Rescues WEE1KO Sensitivity to HU
    International Journal of Molecular Sciences Article A Mutation in DNA Polymerase α Rescues WEE1KO Sensitivity to HU Thomas Eekhout 1,2 , José Antonio Pedroza-Garcia 1,2 , Pooneh Kalhorzadeh 1,2, Geert De Jaeger 1,2 and Lieven De Veylder 1,2,* 1 Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Gent, Belgium; [email protected] (T.E.); [email protected] (J.A.P.-G.); [email protected] (P.K.); [email protected] (G.D.J.) 2 Center for Plant Systems Biology, VIB, 9052 Gent, Belgium * Correspondence: [email protected] Abstract: During DNA replication, the WEE1 kinase is responsible for safeguarding genomic integrity by phosphorylating and thus inhibiting cyclin-dependent kinases (CDKs), which are the driving force of the cell cycle. Consequentially, wee1 mutant plants fail to respond properly to problems arising during DNA replication and are hypersensitive to replication stress. Here, we report the identification of the pola-2 mutant, mutated in the catalytic subunit of DNA polymerase α, as a suppressor mutant of wee1. The mutated protein appears to be less stable, causing a loss of interaction with its subunits and resulting in a prolonged S-phase. Keywords: replication stress; DNA damage; cell cycle checkpoint Citation: Eekhout, T.; Pedroza- 1. Introduction Garcia, J.A.; Kalhorzadeh, P.; De Jaeger, G.; De Veylder, L. A Mutation DNA replication is a highly complex process that ensures the chromosomes are in DNA Polymerase α Rescues correctly replicated to be passed onto the daughter cells during mitosis. Replication starts WEE1KO Sensitivity to HU. Int.
    [Show full text]
  • PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME from $I(TERMOTOGA MARITIMA)
    Europäisches Patentamt *EP000544789B1* (19) European Patent Office Office européen des brevets (11) EP 0 544 789 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C12N 15/54, C12N 9/12 of the grant of the patent: 05.03.2003 Bulletin 2003/10 (86) International application number: PCT/US91/05753 (21) Application number: 91915802.2 (87) International publication number: (22) Date of filing: 13.08.1991 WO 92/003556 (05.03.1992 Gazette 1992/06) (54) PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM $i(TERMOTOGA MARITIMA) GEREINIGTES THERMOSTABILES NUKLEINSÄURE-POLYMERASEENZYM AUS THERMOTOGA MARITIMA ENZYME D’ACIDE NUCLEIQUE THERMOSTABLE PURIFIEE PROVENANT DE L’EUBACTERIE $i(THERMOTOGA MARITIMA) (84) Designated Contracting States: (74) Representative: Poredda, Andreas et al AT BE CH DE DK ES FR GB GR IT LI LU NL SE Roche Diagnostics GmbH, Patentabteilung, (30) Priority: 13.08.1990 US 567244 Sandhofer Strasse 116 68305 Mannheim (DE) (43) Date of publication of application: 09.06.1993 Bulletin 1993/23 (56) References cited: • CHEMICAL ABSTRACTS, vol. 105, no. 5, 04 (73) Proprietor: F. HOFFMANN-LA ROCHE AG August 1986, Columbus, OH (US); R. HUBER et 4002 Basel (CH) al., p. 386, AN 38901u • JOURNAL OF BIOLOGICAL CHEMISTRY, vol. (72) Inventors: 264, no. 11, 15 April 1989, American Society for • GELFAND, David, H. Biochemistry & Molecular Biology Inc., Oakland, CA 94611 (US) Baltimore, MD (US); F.C. LAWYER et al., pp. • LAWYER, Frances, C. 6427-6437 Oakland, CA 94611 (US) • STOFFEL, Susanne El Cerrito, CA 94530 (US) Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted.
    [Show full text]
  • Labeled in Thecourse of Glycolysis, Since Phosphoglycerate Kinase
    THE STATE OF MAGNESIUM IN CELLS AS ESTIMATED FROM THE ADENYLATE KINASE EQUILIBRIUM* BY TRWIN A. RoSE THE INSTITUTE FOR CANCER RESEARCH, PHILADELPHIA Communicated by Thomas F. Anderson, August 30, 1968 Magnesium functions in many enzymatic reactions as a cofactor and in com- plex with nucleotides acting as substrates. Numerous examples of a possible regulatory role of Mg can be cited from studies with isolated enzymes,'- and it is known that Mg affects the structural integrity of macromolecules such as trans- fer RNA" and functional elements such as ribosomes.'0 The major problem in translating this information on isolated preparations to the functioning cell is the difficulty in determining the distribution of Mg and the nucleotides among the free and complexed forms that function in the region of the cell for which this information is desired. Nanningall based an attempt to calculate the free Mg2+ and Ca2+ ion concentrations of frog muscle on the total content of these metals and of the principal known ligands (adenosine 5'-triphosphate (ATP), creatine-P, and myosin) and the dissociation constants of the complexes. However, this method suffers from the necessity of evaluating the contribution of all ligands as well as from the assumption that all the known ligands are contributing their full complexing capacity. During studies concerned with the control of glycolysis in red cells and the control of the phosphoglycerate kinase step in particular, it became important to determine the fractions of the cell's ATP and adenosine 5'-diphosphate (ADP) that were present as Mg complexes. Just as the problem of determining the distribution of protonated and dissociated forms of an acid can be solved from a knowledge of pH and pKa of the acid, so it would be possible to determine the liganded and free forms of all rapidly established Mg complexes from a knowledge of Mg2+ ion concentration and the appropriate dissociation constants.
    [Show full text]
  • Early Modifications of Gene Expression Induced in Liver by Azo-Dye Diet
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 206, number 2 FEBS 4070 October 1986 Early modifications of gene expression induced in liver by azo-dye diet EugCnia Lamas, Fabien Schweighoffer and Axe1 Kahn Unit& de Recherches en GP&tique et Pathologie Mol&ulaires, INSERM U 129, CHU COCHIN, 24, Rue du Faubourg Saint Jacques, 75674 Paris Cedex 14, France Received 5 August 1986 The expression and regulation of the phosphoenolpyruvate carboxykinase gene were not grossly modified by feeding rats a 3’-methyl-4-(dimethylamino)azobenzene-containing diet despite maximum expression of the L-type pyruvate kinase gene being dramatically reduced as early as the 24th hour of the carcinogenic diet. Inhibition of aldolase B mRNA synthesis occurred more slowly, being maximum at the 3rd day. After stopping administration of the carcinogen, a very rapid, but transient increase of the L-type pyruvate kinase mRNA was observed at the 24th hour, whereas aldolase B mRNA increased only slowly. The amount of aldolase A mRNA fell quickly after termination of carcinogen administration, levels being normal at the 2nd-3rd day. At this time, the histological structure of the liver was indistinguishable from that of animals still receiving the azo-dye diet. It appears, therefore, that in the rat both administration and withdrawal of the azo-dye carcinogen induce rapid modifications of the expression of some genes, before any cellular modification is distinguishable. Azo-dye diet mRNA Hepatocarcinogenesis Phosphoenolpyruvate carboxykinase Aldolase Pyruvate kinase 1. INTRODUCTION some genes. Such a possibility is of theoretical im- portance because it could constitute the basis for The azo-dye 3’-methyl-4-(dimethylamino)azo- the carcinogenic action of the dye.
    [Show full text]
  • Interaction of 6-Phosphofructo-2-Kinase/Fructose-2,6- Bisphosphatase (PFK-2/Fbpase-2) with Glucokinase Activates Glucose Phospho
    Interaction of 6-Phosphofructo-2-Kinase/Fructose-2,6- Bisphosphatase (PFK-2/FBPase-2) With Glucokinase Activates Glucose Phosphorylation and Glucose Metabolism in Insulin-Producing Cells Laura Massa,1 Simone Baltrusch,1 David A. Okar,2,3 Alex J. Lange,2 Sigurd Lenzen,1 and Markus Tiedge1 The bifunctional enzyme 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase (PFK-2/FBPase-2) was re- cently identified as a new intracellular binding partner he enzyme glucokinase (GK) plays a pivotal role for glucokinase (GK). Therefore, we studied the impor- in the recognition of glucose in pancreatic tance of this interaction for the activity status of GK ␤-cells and the regulation of glucose metabolism and glucose metabolism in insulin-producing cells by Tin the liver (1–7). In pancreatic ␤-cells, GK acts overexpression of the rat liver and pancreatic islet as a glucose sensor and catalyzes the rate-limiting step for isoforms of PFK-2/FBPase-2. PFK-2/FBPase-2 overex- initiation of glucose-induced insulin secretion (6). GK is pression in RINm5F-GK cells significantly increased the regulated in a complex manner in pancreatic ␤-cells by GK activity by 78% in cells expressing the islet isoform, posttranslational modifications of the enzyme protein that by 130% in cells expressing the liver isoform, and by mainly depend on the intracellular glucose concentration 116% in cells expressing a cAMP-insensitive liver S32A/ (8–13). These posttranslational mechanisms of GK activity H258A double mutant isoform. Only in cells overex- regulation are comprised of conformational changes pressing the wild-type liver PFK-2/FBPase-2 isoform (14,15), sulfhydryl-group conversions (16–18), and inter- was the increase of GK activity abolished by forskolin, ␤ apparently due to the regulatory site for phosphoryla- actions with -cell matrix proteins (13,19), insulin gran- tion by a cAMP-dependent protein kinase.
    [Show full text]
  • Genome Analysis and Classification of Novel Species Flavobacterium Gabrieli
    NOTICE: The copyright law of the United States (Title 17, United States Code) governs the making of reproductions of copyrighted material. One specified condition is that the reproduction is not to be "used for any purpose other than private study, scholarship, or research." If a user makes a request for, or later uses a reproduction for purposes in excess of "fair use," that user may be liable for copyright infringement. RESTRICTIONS: This student work may be read, quoted from, cited, for purposes of research. It may not be published in full except by permission of the author. 1 Kirsten Fischer Introduction Microbial Systematics and Taxonomy The diversity of bacteria is truly immense and the discovery of new species and higher taxonomic groups happens quite frequently, as evidenced by the ever expanding tree of life (Hug et al., 2016). The classification of prokaryotes, bacteria especially, is formally regulated by the International Committee on the Systematics of Prokaryotes and has experienced rapid change over the last fifty years. However, some feel that these rules could be even stricter for proper organization of taxonomy (Tindall et al., 2010). Problems occur with the integration of newer methodologies, which creates some challenges for the researcher attempting to publish a novel species. For example, some DNA sequences that are deposited in databases are not accurate (Clarridge, 2004). Taxonomy is an artificial system that works based on the intuition of scientists rather than strict, specific standards (Konstantinidis & Tiedje, 2005). Tindall advocates that a strain shown to be a novel taxon should be characterized “as comprehensively as possible” and abide by the framework established in the Bacteriological Code (2010).
    [Show full text]
  • DNA Polymerase V Activity Is Autoregulated by a Novel Intrinsic DNA-Dependent
    1 2 DNA polymerase V activity is autoregulated by a novel intrinsic DNA-dependent 3 ATPase 4 Aysen L. Erdem1, Malgorzata Jaszczur1, Jeffrey G. Bertram1, Roger Woodgate2, Michael M. Cox3 & 5 Myron F. Goodman1 6 1Departments of Biological Sciences and Chemistry, University of Southern California, University 7 Park, Los Angeles, California 90089-2910, USA. 2Laboratory of Genomic Integrity, National 8 Institute of Child Health and Human Development, National Institutes of Health, Bethesda, 9 Maryland 20892-3371, USA. 3Department of Biochemistry, University of Wisconsin-Madison, 10 Madison, Wisconsin 53706, USA. 11 12 Escherichia coli DNA polymerase V (pol V), a heterotrimeric complex composed of UmuD′2C, 13 is marginally active. ATP and RecA play essential roles in the activation of pol V for DNA 14 synthesis including translesion synthesis (TLS). We have established three features of the roles 15 of ATP and RecA. 1) RecA-activated DNA polymerase V (pol V Mut), is a DNA-dependent 16 ATPase; 2) bound ATP is required for DNA synthesis; 3) pol V Mut function is regulated by 17 ATP, with ATP required to bind primer/template (p/t) DNA and ATP hydrolysis triggering 18 dissociation from the DNA. Pol V Mut formed with an ATPase-deficient RecA E38K/K72R 19 mutant hydrolyzes ATP rapidly, establishing the DNA-dependent ATPase as an intrinsic 20 property of pol V Mut distinct from the ATP hydrolytic activity of RecA when bound to 21 single-stranded (ss)DNA as a nucleoprotein filament (RecA*). No similar ATPase activity or 22 autoregulatory mechanism has previously been found for a DNA polymerase.
    [Show full text]